It is a pharma private limited company based in New Delhi, Delhi, India, established in 2018.
2018 | New Delhi, Delhi, India | ActiveLymphomed Pharma Private Limited, a active private limited company, was established on 28 March 2018 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999DL2018PTC331736. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Juhi Kumari (Director), Prabhat Kumar Singh (Director), Lal Ratnakar (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at F 90/33, Okhla, Phase-1, Okhla Industrial Area,, New Delhi, Delhi, 110020.
U74999DL2018PTC331736
331736
28 March 2018
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Lymphomed Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Juhi Kumari | Director | 02 Nov 2018 | Current |
| Prabhat Kumar Singh | Director | 28 Mar 2018 | Current |
| Lal Ratnakar | Director | 28 Mar 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lymphomed Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 481.69% increase. The company also saw a substantial improvement in profitability, with a 104.63% increase in profit. The company's net worth Soared by an impressive increase of 10.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Lymphomed Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lymphomed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lymphomed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lymphomed Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Lymphomed Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Progress on Lymphomed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was documented.
The activity Juhi Kumari was appointed as a Director was appointed as a Director on 02 Nov 2018 & has been associated with this company since 7 years 1 month . was completed.
Progress on Prabhat Kumar Singh was appointed as a Director was appointed as a Director on 28 Mar 2018 & has been associated with this company since 7 years 8 months . was documented.
Progress on Lal Ratnakar was appointed as a Director was appointed as a Director on 28 Mar 2018 & has been associated with this company since 7 years 8 months . was documented.
Lymphomed Pharma Private Limited was registered on 28 Mar 2018 with Roc Delhi & aged 7 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Lymphomed Pharma Private Limited is U74999DL2018PTC331736.
Lymphomed Pharma Private Limited is headquartered at F 90/33, Okhla, Phase-1, Okhla Industrial Area,, New Delhi, Delhi, 110020.
Lymphomed Pharma Private Limited was incorporated on 28 March 2018.
The current directors of Lymphomed Pharma Private Limited are
The primary industry of Lymphomed Pharma Private Limited is Pharma.
Lymphomed Pharma Private Limited is unlisted.
The authorized capital of Lymphomed Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX